Duane Mitchell
University of Florida
H-index: 55
North America-United States
Top articles of Duane Mitchell
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells | Molecular Therapy Methods & Clinical Development | Elizabeth Ogando-Rivas Paul Castillo Changlin Yang Vrunda Trivedi Dingpeng Zhang | 2024/3/14 |
Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer | 2024/2/20 | ||
Blocking Immune Checkpoint—LAIR1: Disrupting the LAIR1—FXIII-A—Collagen Immunosuppressive Circuit for Enhanced Antitumor Therapeutics | Jianping Huang Haipeng Tao Dongjiang Chen Changlin Yang Duy Nguyen | 2024/4/10 | |
CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia | Transplantation and Cellular Therapy | John A Ligon Paul Castillo Xiaojie Ma Linchun Jin Haipeng Tao | 2024/2/1 |
Abstract LB332: Spatial transcriptomic and proteomic analysis of the treatment resistant slow cycling micro environment in GBM | Cancer Research | Avirup Chakraborty Diana Feier Aryeh Silver Changlin Yang Miruna Anica | 2024/4/5 |
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors | Genome Medicine | Vrunda Trivedi Changlin Yang Kelena Klippel Oleg Yegorov Christina von Roemeling | 2024/1/25 |
CA-4948 (emavusertib) improves treatment response of preclinical metastatic brain melanoma to anti-PD-1 immune checkpoint blockade | Cancer Research | Christina A von Roemeling Bently P Doonan Amanda M Acevedo Jeet A Patel Savannah L Carpenter | 2024/3/22 |
Comment on Mahajan, S.; Schmidt, M.H.H. Distinct Lineage of Slow-Cycling Cells Amidst the Prevailing Heterogeneity in Glioblastoma. Cancers 2023, 15, 3843 | Cancers | Changlin Yang Duane A Mitchell Loic P Deleyrolle | 2024/1/9 |
Unleashing CAR T cell activity against osteosarcoma using tumor specific RNA-based vaccination | Cancer Research | Arnav Barpujari Rui Liu Elizabeth Ogando-Rivas Xiaojie Ma Haipeng Taoa | 2024/3/22 |
KR158 spheres harboring slow-cycling cells recapitulate GBM features in an immunocompetent system | bioRxiv | Avirup Chakraborty Changlin Yang Jesse L Kresak Aryeh Silver Diana Feier | 2024 |
Stem cell immunomodulatory therapy for covid-19 infection | 2023/6/15 | ||
Multimodal in vivo tracking of chimeric antigen receptor T cells in preclinical glioblastoma models | Investigative Radiology | Wei Emma Wu Edwin Chang Linchun Jin Shiqin Liu Ching-Hsin Huang | 2023 |
Cellular cancer immunotherapy development and manufacturing in the clinic | Graeme A Fenton Duane A Mitchell | 2023/3/1 | |
Methods, kits, and compositions for enhancing cellular therapy | 2023/8/24 | ||
Development of personalized RNA-based immunotherapeutics for glioblastom | Cancer Research | Vrunda Trivedi Changlin Yang Oleg Yegorov Kelena Klippel Graeme Fenton | 2023/4/4 |
IMMU-20. MESSENGER RNA CHALLENGE RAPIDLY PREDICTS BRAIN TUMOR RESPONSIVENESS TO CHECKPOINT INHIBITORS | Neuro-Oncology | Paul Castillo Elizabeth Ogando-Rivas Hillary Geffrard Alfonso Pepe Ruixuan Liu | 2023/11/1 |
772 Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy | Bently Doonan Christiana Shaw Ji-Hyun Lee Eugenio Manso Hector Mendez-Gomez | 2023/11/1 | |
Materials and methods for sensitizing tumors to immune response | 2023/12/28 | ||
IMMU-06. SYSTEMIC MRNA VACCINES RESET IMMUNOGENICITY AGAINST DIFFUSE MIDLINE GLIOMA | Neuro-Oncology | James McGuiness Frances Weidert Anna DeVries John Ligon Dingpeng Zhang | 2023/6 |
Three-dimensional bioconjugated liquid-like solid (LLS) enhance characterization of solid tumor-Chimeric antigen receptor T cell interactions | bioRxiv | Duy T Nguyen Ruixuan Liu Elizabeth Ogando-Rivas Alfonso Pepe Diego Pedro | 2023/2/21 |
